IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
1-Year Return
17.25%
This Quarter Return
-9.61%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$216M
AUM Growth
-$53.3M
(-20%)
Cap. Flow
-$18.3M
Cap. Flow
% of AUM
-8.46%
Top 10 Holdings %
Top 10 Hldgs %
56.68%
Holding
66
New
2
Increased
13
Reduced
15
Closed
8
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$4.58M |
| 2 |
CELG
Celgene Corp
CELG
|
$2.83M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$2.45M |
| 4 |
AMRN
Amarin Corp
AMRN
|
$1.85M |
| 5 |
Sangamo Therapeutics
SGMO
|
$1.81M |
Top Sells
| 1 |
Halozyme
HALO
|
$6.56M |
| 2 |
Exelixis
EXEL
|
$6.01M |
| 3 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$3.07M |
| 4 |
Biogen
BIIB
|
$2.56M |
| 5 |
Iovance Biotherapeutics
IOVA
|
$2.54M |
Sector Composition
| 1 | Healthcare | 99.71% |
